SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021920
Filing Date
2020-05-06
Accepted
2020-05-06 16:08:02
Documents
49
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nltx-10q_20200331.htm 10-Q 1316282
2 EX-10.1 nltx-ex101_86.htm EX-10.1 74451
3 EX-31.1 nltx-ex311_8.htm EX-31.1 15794
4 EX-31.2 nltx-ex312_6.htm EX-31.2 15689
5 EX-32.1 nltx-ex321_7.htm EX-32.1 9186
  Complete submission text file 0001564590-20-021920.txt   4074339

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nltx-20200331.xml EX-101.INS 672935
7 XBRL TAXONOMY EXTENSION SCHEMA nltx-20200331.xsd EX-101.SCH 31391
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nltx-20200331_cal.xml EX-101.CAL 39123
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nltx-20200331_def.xml EX-101.DEF 72494
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nltx-20200331_lab.xml EX-101.LAB 278189
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nltx-20200331_pre.xml EX-101.PRE 201543
Mailing Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
Business Address SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102 206-732-2133
Neoleukin Therapeutics, Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 20852650
SIC: 2834 Pharmaceutical Preparations